![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/439 | (2006.01) |
A61P 27/10 | (2006.01) | ||
A61K 9/00 | (2006.01) | ||
A61K 47/38 | (2006.01) | ||
A61K 47/40 | (2006.01) |
(11) | Number of the document | 3542798 |
(13) | Kind of document | T |
(96) | European patent application number | 19171214.0 |
Date of filing the European patent application | 2014-08-22 | |
(97) | Date of publication of the European application | 2019-09-25 |
(45) | Date of publication and mention of the grant of the patent | 2025-03-19 |
(46) | Date of publication of the claims translation | 2025-06-10 |
(30) | Number | Date | Country code |
201361871215 P | 2013-08-28 | US | |
201361882998 P | 2013-09-26 | US | |
201361904510 P | 2013-11-15 | US | |
201361917620 P | 2013-12-18 | US | |
201461938438 P | 2014-02-11 | US |
(72) |
HORN, Gerald , US
NORDAN, Lee , US
|
(73) |
Lenz Therapeutics Operations, Inc. ,
201 Lomas Santa Fe Drive, Suite 300, Solana Beach, CA 92075,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Aceklidinas, skirtas panaudoti gydant presbiopiją |
ACECLIDINE FOR USE IN THE TREATMENT OF PRESBYOPIA |
Payment date | Validity (years) | Amount | |
2025-07-31 | 12 | 289.00 EUR |
2026-08-22 |